Collaboration with BioScience Valuation GmbH
Togetherwith BioScience Valuation GmbH, a provider of evidence-based valuations and market models, FCF Life Sciences focuses on the development of integrated financial models as well as budgets.
Service Portfolio
for Pharmaceutical companies:
- Determination of project value and support of portfolio management decisions
- Assessment of in-licensing candidates and potential M&A transactions
- Drug’s sales forecast
- Increase R&D productivity
- Optimization of resource and capacity planning
for Biotech / MedTech companies:
- Identification of licensing partners, optimizing term sheets and leveraging negotiations
- Preparation of funding rounds to attract investors
for Healthcare companies and organizations:
- Assessment of economic impact of policies
- Facilitation of healthcare policy decisions
for Investors:
- Facilitation of investment decisions
- Support of due diligence
Notable Past Clients
- AiCuris GmbH & Co. KG
- Alligator Bioscience AB
- Bayer HealthCare
- Boehringer Ingelheim
- Cell Medica
- Daiichi Sankyo Europe
- Ferring Pharmaceuticals
- Fresenius Biotech GmbH
- Grünenthal GmbH
- Heidelberg Pharma
- Spirogene Pty Ltd
- Hoffman-La Roche Ltd.
- Janus Developments SL
- Jerini AG
- MediGene AG
- Merck KGaA
- MorphoSys AG
- Novalead Pharma Pvt. Ltd.
- Oryzon SA
- Rentschler Biotechnologie
- Schwarz Pharma AG
- Solvay Pharmaceuticals
- The Genetics Company
- UCB Pharma SA
- …
